- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced NSCLC
Total 6635 results
-
CStone PharmaceuticalsCompleted
-
M.D. Anderson Cancer CenterCompletedAdvanced CancerUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Royal Marsden NHS Foundation TrustAstraZeneca; Institute of Cancer Research, United KingdomCompletedAdvanced CancerUnited Kingdom
-
M.D. Anderson Cancer CenterTerminated
-
Dragonboat Biopharmaceutical Company LimitedUnknown
-
Merck Sharp & Dohme LLCCompleted
-
Bristol-Myers SquibbCompleted
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Unknown
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCompletedAdvanced CancerUnited States, Argentina, Chile, Guatemala
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Nanjing Medical UniversityCompleted
-
Scottsdale HealthcareTranslational Genomics Research Institute; National Foundation for Cancer ResearchCompletedAdvanced CancerUnited States
-
M.D. Anderson Cancer CenterYukiguni Maitake Company Ltd.Terminated
-
M.D. Anderson Cancer CenterCompletedAdvanced CancerUnited States
-
Seoul National University HospitalUnknownDurvalumab + Tremelimumab Combination Treatment, Pulmonary Sarcomatoid Carcinoma, NSCLCKorea, Republic of
-
SynDevRx, Inc.CompletedAdvanced Solid Tumors | Metastasis | Neoplasm | Advanced MalignancyUnited States
-
PfizerTerminatedALK or ROS1-positive NSCLCChina
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
National Health Research Institutes, TaiwanTerminatedHead and Neck Cancer | NSCLCTaiwan
-
Xizang Haisco Pharmaceutical Co., LtdRecruiting
-
Tianjin ConjuStar Biologics Co., Ltd.Recruiting
-
China-Japan Friendship HospitalRecruitingAdvanced Solid TumorChina
-
AkesoNot yet recruiting
-
Centre Leon BerardRecruiting
-
Sichuan Honghe Biotechnology Co., Ltd.Recruiting
-
SelecxineRecruitingAdvanced Solid TumorUnited States, Australia, Korea, Republic of
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Bio-Thera SolutionsRecruitingAdvanced Solid TumorsChina
-
Betta Pharmaceuticals Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.RecruitingAdvanced Solid TumorChina
-
ImmuneOncia Therapeutics Inc.RecruitingAdvanced CancerKorea, Republic of
-
Chia Tai Tianqing Pharmaceutical Group Nanjing...Recruiting
-
Nanjing Leads Biolabs Co.,LtdRecruiting
-
Shandong TheraWisdom Biopharma Co., Ltd.RecruitingAdvanced MalignanciesChina
-
Chang Gung Memorial HospitalRecruiting
-
Sunnybrook Health Sciences CentreUniversity of Toronto; Princess Margaret Hospital, CanadaRecruiting
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
Yonsei UniversityRecruitingAdvanced CancerKorea, Republic of
-
Innovent Biologics (Suzhou) Co. Ltd.Recruiting
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Italy, Korea, Republic of, Spain, Belgium, Canada, Germany, United States, Hong Kong, Hungary, China, Czechia, Taiwan, France, Poland, Thailand, Netherlands
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Recruiting
-
Merck Sharp & Dohme LLCAstraZenecaRecruitingAdvanced Solid NeoplasmsUnited States, Argentina, Australia, Canada, Colombia, Denmark, France, Guatemala, Ireland, Israel, Japan, Korea, Republic of, Mexico, Peru, Romania, Russian Federation, Spain, Switzerland, Turkey, United Kingdom, Italy
-
Shanghai Pharmaceuticals Holding Co., LtdCompleted
-
Shenzhen NewDEL Biotech, Co., LtdShenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.Enrolling by invitation
-
Canadian Cancer Trials GroupPfizerActive, not recruitingAdvanced Rare TumoursCanada
-
Bristol-Myers SquibbCompletedAdvanced Solid TumorsChina
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States